Predictive Value of Fasting Glucose, Postload Glucose, and Hemoglobin A1c on Risk of Diabetes and Complications in Chinese Adults

被引：133

作者：

Lu, Jieli ^{[1
]}

He, Jiang ^{[2
]}

Li, Mian ^{[1
]}

Tang, Xulei ^{[3
]}

Hu, Ruying ^{[4
]}

Shi, Lixin ^{[5
]}

Su, Qing ^{[6
]}

Peng, Kui ^{[1
]}

Xu, Min ^{[1
]}

Xu, Yu ^{[1
]}

Chen, Yuhong ^{[1
]}

Yu, Xuefeng ^{[7
]}

Yan, Li ^{[8
]}

Wang, Tiange ^{[1
]}

Zhao, Zhiyun ^{[1
]}

Qin, Guijun ^{[9
]}

Wan, Qin ^{[10
]}

Chen, Gang ^{[11
]}

Dai, Meng ^{[1
]}

Zhang, Di ^{[1
]}

Gao, Zhengnan ^{[12
]}

Wang, Guixia ^{[13
]}

Shen, Feixia ^{[14
]}

Luo, Zuojie ^{[15
]}

Qin, Yingfen ^{[15
]}

Chen, Li ^{[16
]}

Huo, Yanan ^{[17
]}

Li, Qiang ^{[18
]}

Ye, Zhen ^{[4
]}

Zhang, Yinfei ^{[19
]}

Du, Rui ^{[1
]}

Cheng, Di ^{[1
]}

Liu, Chao ^{[20
]}

Wang, Youmin ^{[21
]}

Wu, Shengli ^{[22
]}

Yang, Tao ^{[23
]}

Deng, Huacong ^{[24
]}

Li, Donghui ^{[25
]}

Lai, Shenghan ^{[26
]}

Bloomgarden, Zachary T. ^{[27
]}

Chen, Lulu ^{[28
]}

Zhao, Jiajun ^{[29
]}

Mu, Yiming ^{[30
]}

Ning, Guang ^{[1
]}

Wang, Weiqing ^{[1
]}

Bi, Yufang ^{[1
]}

机构：

[1] Shanghai Jiao Tong Univ, Shanghai Natl Clin Res Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis,Sch Med, Key Lab Endocrine Tumors,Minist Shanghai,Ruijin H, Shanghai, Peoples R China

[2] Tulane Univ, Dept Epidemiol, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA

[3] Lanzhou Univ, Hosp 1, Lanzhou, Gansu, Peoples R China

[4] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China

[5] Guiyang Med Coll, Affiliated Hosp, Guiyang, Guizhou, Peoples R China

[6] Shanghai Jiao Tong Univ, Xinhua Hosp, Shanghai, Peoples R China

[7] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China

[8] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou, Guangdong, Peoples R China

[9] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China

[10] Southwest Med Univ, Affiliated Hosp, Luzhou, Peoples R China

[11] Fujian Med Univ, Fujian Prov Hosp, Fuzhou, Fujian, Peoples R China

[12] Dalian Municipal Cent Hosp, Dalian, Peoples R China

[13] Jilin Univ, Hosp 1, Changchun, Jilin, Peoples R China

[14] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Peoples R China

[15] Guangxi Med Univ, Affiliated Hosp 1, Nanning, Peoples R China

[16] Shandong Univ, Qilu Hosp, Jinan, Shandong, Peoples R China

[17] Nanchang Univ, Jiangxi Prov Peoples Hosp, Nanchang, Jiangxi, Peoples R China

[18] Harbin Med Univ, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China

[19] Cent Hosp Shanghai Jiading Dist, Shanghai, Peoples R China

[20] Jiangsu Prov Hosp Integrat Chinese & Western Med, Nanjing, Jiangsu, Peoples R China

[21] Anhui Med Univ, Affiliated Hosp 1, Hefei, Anhui, Peoples R China

[22] Karamay Municipal Peoples Hosp, Karamay, Xinjiang, Peoples R China

[23] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China

[24] Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China

[25] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA

[26] Johns Hopkins Univ, Sch Med, Baltimore, MD USA

[27] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[28] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China

[29] Shandong Univ, Shandong Prov Hosp, Jinan, Shandong, Peoples R China

[30] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China

来源：

DIABETES CARE | 2019年 / 42卷 / 08期

基金：

中国国家自然科学基金;

关键词：

CARDIOVASCULAR-DISEASE; NONDIABETIC HYPERGLYCEMIA; GLYCATED HEMOGLOBIN; REGRESSION-MODELS; MORTALITY; COHORT; A1C; PREVALENCE; GLYCEMIA; MEN;

D O I：

10.2337/dc18-1390

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

OBJECTIVE Uncertainty remains regarding the predictive value of various glycemic measures as they relate to the risk of diabetes and its complications. Using the cutoffs recommended by the American Diabetes Association's 2010 criteria, we determined the associations of fasting plasma glucose (FPG), 2-h postload glucose (2h-PG), and HbA(1c) with the outcomes. RESEARCH DESIGN AND METHODS Baseline medical history, FPG, 2h-PG, and HbA(1c) were obtained from a population-based cohort of 193,846 adults aged >= 40 years in China during 2011-2012. A follow-up visit was conducted during 2014-2016 in order to assess incident diabetes, cardiovascular disease (CVD), cancer, and mortality. RESULTS We documented 8,063 cases of diabetes, 3,014 CVD-related events, 1,624 cases of cancer, and 2,409 deaths during up to 5 years of follow-up. Multivariable-adjusted risk ratios (95% CIs) of diabetes associated with prediabetes based on FPG of 100-125 mg/dL, 2h-PG of 140-199 mg/dL, or HbA(1c) of 5.7-6.4% (39-47 mmol/mol) were 1.60 (1.43-1.79), 2.72 (2.43-3.04), and 1.49 (1.36-1.62), respectively. Restricted cubic spline analyses suggested J-shaped associations of FPG, 2h-PG, and HbA(1c) levels with CVD, cancer, and mortality. Multivariable-adjusted hazard ratios (95% CIs) associated with untreated diabetes based on FPG >= 126 mg/dL, 2h-PG >= 200 mg/dL, or HbA(1c) >= 6.5% (48 mmol/mol) were 1.18 (1.05-1.33), 1.31 (1.18-1.45), and 1.20 (1.07-1.34) for CVD; 1.10 (0.92-1.32), 1.44 (1.25-1.67), and 1.08 (0.92-1.28) for cancer; and 1.37 (1.20-1.57), 1.57 (1.41-1.76), and 1.33 (1.17-1.52) for mortality, respectively. 2h-PG remained significantly associated with outcomes in models including FPG and HbA(1c) as spline terms. Furthermore, 2h-PG significantly improved the ability of the C statistic to predict diabetes, CVD, and mortality. CONCLUSIONS 2h-PG remains independently predictive of outcomes in models including FPG and HbA(1c). Therefore, in addition to FPG and HbA(1c), routine testing of 2h-PG should be considered in order to better assess the risks of outcomes.

引用

页码：1539 / 1548

页数：10

共 50 条

[1] Combining glycosylated hemoglobin A1c and fasting plasma glucose for diagnosis of type 2 diabetes in Chinese adults
Mo, Miao
Zhong, Weijian
Zhao, Genming
Ruan, Ye
Zhang, Hua
Shi, Liang
Lu, Dajiang
Yang, Qundi
Li, Yanyun
Jiang, Qingwu
Li, Rui
Xu, Wang-Hong
BMC ENDOCRINE DISORDERS, 2013, 13
[2] Plasma glucose and hemoglobin A1c for the detection of diabetes in Chinese adults
Xu, Yu
Zhao, Wenhua
Wang, Weiqing
Bi, Yufang
Li, Jianhong
Mi, Shengquan
Xu, Min
Lu, Jieli
Wang, Tiange
Li, Mian
Wang, Zhuoqun
Jiang, Yong
Wang, Limin
Wang, Linhong
Dai, Meng
Zhang, Di
Lai, Shenghan
Ning, Guang
JOURNAL OF DIABETES, 2016, 8 (03) : 378 - 386
[3] Applicability of a combination of hemoglobin A1c and fasting plasma glucose in population-based prediabetes screening
Okosun, Ike S.
Davis-Smith, Monique
Seale, J. Paul
Ngulefac, John
JOURNAL OF DIABETES, 2012, 4 (04) : 407 - 416
[4] Hemoglobin A1c, Fasting Glucose, and Cardiovascular Risk in a Population With High Prevalence of Diabetes The Strong Heart Study
Wang, Hong
Shara, Nawar M.
Lee, Elisa T.
Devereux, Richard
Calhoun, Darren
de Simone, Giovanni
Umans, Jason G.
Howard, Barbara V.
DIABETES CARE, 2011, 34 (09) : 1952 - 1958
[5] Cardiometabolic Risk Profiles and Carotid Atherosclerosis in Individuals With Prediabetes Identified by Fasting Glucose, Postchallenge Glucose, and Hemoglobin A1c Criteria
Marini, Maria A.
Succurro, Elena
Castaldo, Ersilia
Cufone, Sabrina
Arturi, Franco
Sciacqua, Angela
Lauro, Renato
Hribal, Marta L.
Perticone, Francesco
Sesti, Giorgio
DIABETES CARE, 2012, 35 (05) : 1144 - 1149
[6] Risks of Diabetic Nephropathy with Variation in Hemoglobin A1c and Fasting Plasma Glucose
Lin, Cheng-Chieh
Chen, Ching-Chu
Chen, Fei-Na
Li, Chia-Ing
Liu, Chiu-Shong
Lin, Wen-Yuan
Yang, Sing-Yu
Lee, Cheng-Chun
Li, Tsai-Chung
AMERICAN JOURNAL OF MEDICINE, 2013, 126 (11) : 1017.e1 - 1017.e10
[7] Is there a Predictive Value of Hemoglobin A1C for Complications of Cardiac Surgery?
Ozturk, Selen
Kayacoglu, Ilyas
Sensoz, Yavuz
Ozcelik, Safa
Arslan, Yucesin
Ozturk, Ibrahim
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2021, 31 (06): : 686 - 693
[8] Fasting Plasma Glucose and Hemoglobin A1c in Identifying and Predicting Diabetes The Strong Heart Study
Wang, Wenyu
Lee, Elisa T.
Howard, Barbara V.
Fabsitz, Richard R.
Devereux, Richard B.
Welty, Thomas K.
DIABETES CARE, 2011, 34 (02) : 363 - 368
[9] Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c
Zhou, Bin
Sheffer, Kate E.
Bennett, James E.
Gregg, Edward W.
Danaei, Goodarz
Singleton, Rosie K.
Shaw, Jonathan E.
Mishra, Anu
Lhoste, Victor P. F.
Carrillo-Larco, Rodrigo M.
Kengne, Andre P.
Phelps, Nowell H.
Heap, Rachel A.
Rayner, Archie W.
Stevens, Gretchen A.
Paciorek, Chris J.
Riley, Leanne M.
Cowan, Melanie J.
Savin, Stefan
Vander Hoorn, Stephen
Lu, Yuan
Pavkov, Meda E.
Imperatore, Giuseppina
Aguilar-Salinas, Carlos A.
Ahmad, Noor Ani
Anjana, Ranjit Mohan
Davletov, Kairat
Farzadfar, Farshad
Gonzalez-Villalpando, Clicerio
Khang, Young-Ho
Kim, Hyeon Chang
Laatikainen, Tiina
Laxmaiah, Avula
Mbanya, Jean Claude N.
Narayan, K. M. Venkat
Ramachandran, Ambady
Wade, Alisha N.
Zdrojewski, Tomasz
Abbasi-Kangevari, Mohsen
Rahim, Hanan F. Abdul
Abu-Rmeileh, Niveen M.
Adambekov, Shalkar
Adams, Robert J.
Aekplakorn, Wichai
Agdeppa, Imelda A.
Aghazadeh-Attari, Javad
Agyemang, Charles
Ahmadi, Ali
Ahmadi, Naser
Ahmadi, Nastaran
NATURE MEDICINE, 2023, 29 (11) : 2885 - 2901
[10] The Compatibility of Hemoglobin A1c with Oral Glucose Tolerance Test and Fasting Plasma Glucose
Cetin, Elif Guven
Demir, Nazan
Kalkan, Kubra
Ozturkmen, Yuksel Asli
Nazif, Perin
Yucelen, Sumeyra Yildirim
Calim, Aslihan
Borlu, Fatih
Altuntas, Yuksel
MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL, 2020, 54 (03): : 351 - 356

← 1 2 3 4 5 →